EU squabbles over medical device rules; Verinata teams with Teva for prenatal Dx;

 @FierceMedDev: Veracyte nails $28M Series C. Story | Follow @FierceMedDev

 @MarkHFierce: There's still time to submit your nomination for this year's FMD Fierce 15. More | Follow @MarkHFierce

 @DamianFierce: Thoratec is spending up to $56.5M for Terumo's in-development heart device. News | Follow @DamianFierce

> Politicians and industry leaders in the European Union remain divided about how to update their regulatory system for medical devices. Story

> Illumina ($ILMN) won a CE mark for its MiSeqDx cystic fibrosis system, gearing up to market the next-generation sequencing instrument and its assays in Europe. News

> OrthoFix ($OFIX) has launched its Trinity Elite spinal fixation technology in the U.S. Release

> Verinata Health, recently acquired by Illumina, has teamed up with Teva Pharmaceutical Industries ($TEVA) to market its Verifi prenatal diagnostic test in Israel. More

> 2012 Fierce 15 winner T2 Biosystems notched positive data for its T2Hemostat diagnostic, finding that its test accurately correlated to 100% of bleeding events in a study of 26 patients. Item

> MDxHealth ($MDXH) has partnered with Summit Pharmaceuticals to get its epigenetic diagnostics products into Japan. Report

> Silver, which is often added to medical devices to prevent bacteria from sticking, may actually end up accelerating the problem rather than stopping it. Story

Biotech News

 @FierceBiotech: Insmed shares routed on head-to-head antibiotic Phase III results. Story | Follow @FierceBiotech

 @JohnCFierce: The FDA's suvorexant decision was expected. I don't see how weak suvo competes with the generics. It'll be an alternative for non-response. | Follow @JohnCFierce

 @RyanMFierce: Onyx is following the M&A resistance strategy, which Termeer and more recently Martin have used. More | Follow @RyanMFierce

> FDA scraps Merck's high-dose sleep drug, demands weaker version. Story

> Report: China rounds up GlaxoSmithKline staffers in corruption probe. Article

Pharma News

 @FiercePharma: Fresenius Kabi yanks four lots of benztropine mesylate on risk of glass particles, stops distribution to investigate. News | Follow @FiercePharma

 @EricPFierce: ICYMI: FDA approves first non-hormonal treatment for hot flashes. Release | Follow @EricPFierce

> Merck KGaA sees U.S. as "emerging market" for sales growth. More

> Pfizer, Bristol-Myers tout new VTE data on Eliquis, aiming for new use. News

CRO News

> MMS teams up with Datatrak for eClinical heft. Story

> Want to work with Roche? Prepare for high standards. More

> AstraZeneca taps Sarah Cannon for cancer R&D. Article

Biotech IT News

> Ex-Googlers bring Big Data analytics to oncology. News

> Deloitte turns EHR reservoir into health outcomes tool. Article

> J&J teams up with Mount Sinai on bioinformatics project. Story

> Data secrecy and outdated tech exacerbating drug shortages. More